Latest filing published 25 Jun 2026 for Rhythm Pharmaceuticals, INC..
Insider track record
No signal scores available.
Christophe Jean: trading record in brief
Filings by Christophe Jean span 2 companies, the busiest being Rhythm Pharmaceuticals, Inc. and Tercica Inc. In total, 5 filings cover trades dated from 20 May 2008 to 23 June 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 25 June 2026, the filings show an option exercise in Rhythm Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Christophe Jean
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,712 sharesCommon StockSEC:0001104659-26-077867:0
- 4,000 sharesCommon StockSEC:0001104659-25-061714:0
- 3,000 sharesCommon StockSEC:0001104659-24-074766:0
- 3,333 shares0Common stockSEC:0001181431-08-033405:0
4 of 4 declarations
